🇺🇸 FDA
Patent

US 7119066

Modified ciliary neurotrophic factor (CNTF)

granted A61KA61K38/185A61P

Quick answer

US patent 7119066 (Modified ciliary neurotrophic factor (CNTF)) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/185, A61P, A61P25/00, A61P25/14